| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/03/2001 | CA2388934A1 Micro-cluster liquids and methods of making and using them |
| 05/03/2001 | CA2388599A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 05/03/2001 | CA2388338A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 05/03/2001 | CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors |
| 05/03/2001 | CA2387897A1 Complex comprising an igfiie polypeptide-fragment and an igfbp2 polypeptide and its use in the treatment of osteoporosis |
| 05/03/2001 | CA2387506A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 05/03/2001 | CA2387378A1 Processed human chemokines phc-1 and phc-2 |
| 05/03/2001 | CA2385929A1 Use of gdnf for treating corneal defects |
| 05/02/2001 | EP1096008A2 Human G protein-coupled receptor, PFI-014 |
| 05/02/2001 | EP1095936A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 05/02/2001 | EP1095159A1 Bone morphogenic protein |
| 05/02/2001 | EP1095057A1 Matrix metalloproteinase inhibitors containing aminomalonic acid derivatives and peptide backbone modified derivatives thereof |
| 05/02/2001 | EP1095036A1 Cinnamic acid derivatives as cell adhesion molecules |
| 05/02/2001 | EP1095031A1 Antiviral macrocyclic compounds |
| 05/02/2001 | EP1095021A1 Quinoline derivatives |
| 05/02/2001 | EP1095003A1 Cytokine production and tyrosine kinase inhibitors |
| 05/02/2001 | EP1094829A2 Methods for accelerating bone and cartilage growth and repair |
| 05/02/2001 | EP1094815A1 Farnesyl protein transferase inhibitors for treating arthropathies |
| 05/02/2001 | EP1094808A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0750502B1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 05/02/2001 | CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293575A Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as estrofen-like organ-selective medicament without uteroetropic effects |
| 05/02/2001 | CN1293057A Medicine for treating bone fracture and injury |
| 05/02/2001 | CN1293050A Plaster |
| 05/02/2001 | CN1065132C Chinese medicinal preparation for treatment of prolapse of lumbar intervertebral disc |
| 05/02/2001 | CN1065128C Amino acid metal chelate preparation and preparaing method |
| 05/01/2001 | US6225448 1gG /transferrin receptor fusion protein |
| 05/01/2001 | US6225308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy |
| 05/01/2001 | US6225117 Antibodies against human IL-12 |
| 04/26/2001 | WO2001029219A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | WO2001029206A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/26/2001 | WO2001029189A2 Synthetic substrate for tissue formation |
| 04/26/2001 | WO2001029081A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | WO2001029055A2 Novel oligosaccharides, preparation method and pharmaceutical compositions containing same |
| 04/26/2001 | WO2001029049A2 Imidazole derivatives as phosphodiesterase vii inhibitors |
| 04/26/2001 | WO2001029042A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029041A1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 04/26/2001 | WO2001029026A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 04/26/2001 | WO2001029025A2 Tyrosine kinase inhibitors |
| 04/26/2001 | WO2001029000A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028987A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028920A1 Bone substitute material and precursors therefor |
| 04/26/2001 | WO2001028919A1 Hydroxyl apatite material containing tricalcium phosphate, having a microporous structure |
| 04/26/2001 | WO2001028603A1 Formulations for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028602A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028580A2 Modulation of angiogenesis |
| 04/26/2001 | WO2001028579A2 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | WO2001028567A2 Aminoalkylenephosphonates for treatment of bone disorders |
| 04/26/2001 | WO2001028564A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 04/26/2001 | WO2001028547A1 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 04/26/2001 | WO2001028491A2 Method and composition for the treatment of dermatologic diseases |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000056889A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/26/2001 | WO2000055139A3 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | US20010000473 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19950114A1 Tetracalcium phosphate used in bone cement is obtained by reacting calcium hydrogenphosphate and calcium carbonate derived from organic-free alga indurated fabric |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388421A1 Human cub-domain-containing protein and gene encoding the same |
| 04/26/2001 | CA2387580A1 Synthetic substrate for tissue formation |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386408A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | CA2386398A1 Modified peptides and peptidomimetics for use in immunotherapy |
| 04/26/2001 | CA2386049A1 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2385958A1 Inhibitors of proteasomal activity for stimulating bone and hair growth |
| 04/26/2001 | CA2384537A1 Modulation of angiogenesis |
| 04/26/2001 | CA2384240A1 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 04/26/2001 | CA2382877A1 Aminoalkylenephosphonates for treatment of bone disorders |
| 04/25/2001 | EP1094317A1 Method to identify compounds which modulate FRA-1 expression |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093367A1 Protease inhibitors |
| 04/25/2001 | EP0701568B1 New peptide derivatives |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292286A Medicine preparation containing cotton rose leaf extract |
| 04/25/2001 | CN1292274A Chinese medicine preparation for curing necrosis of femoral head |
| 04/25/2001 | CN1064846C Gushifu-external application medicine for curing wind-cold syndrome |
| 04/25/2001 | CN1064841C 骨伤酊 Orthopedics tincture |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222016 Amino acid sequence of protein involved in chromosome partitioning; drug screening of bacteriostats and bactericides; antibodies |
| 04/24/2001 | US6221915 Pharmaceutical compositions |
| 04/24/2001 | US6221913 Dialkyl ureas as calcitonin mimetics |
| 04/24/2001 | US6221907 Tricyclic compounds having activity specific for integrins, particularly alphanubeta3 integrins, method for preparing same, intermediates therefor, use of said compounds as drugs, and pharmaceutical compositions containing same |
| 04/24/2001 | US6221874 Method of treating bone loss by stimulation of calcitonin |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221854 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027140A1 Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death |